drogue – Commercialisation de nouveaux produits énergisants à inhaler par voie nasale

This written question concerns the commercialisation of new stimulant products intended for nasal inhalation. It seeks clarification on the regulatory framework and potential risks associated with these products. The question addresses concerns about public health and consumer safety, particularly regarding the accessibility and marketing of these novel substances to the general public.